Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEPISTREC: SCID Newborn Screening Evaluation
NCT02244450Completed
- Sponsor
- CHU de Nantes
- Start
- Dec 2014
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU de Nantes. Primary endpoint: Cost / efficiency ratio of the implementation of the generalized neonatal screening of SCID at birth at 18 months. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02244450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244450.